World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
14020
World Ranking
13669
National Ranking
286

Overview

Jan van Lunzen is affiliated with ViiV Healthcare in Spain. Their research spans multiple areas within medicine, with a focus on immunology and microbiology. The primary fields of study include Medicine, represented in 34 publications, and Immunology and Microbiology, with 18 publications. Within these areas, van Lunzen has contributed significantly to subfields such as Virology, Infectious Diseases, Epidemiology, Immunology, and Emergency Medicine.

The scientist's work emphasizes topics related to HIV and associated health complications. Major research subjects comprise:

  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • Cytomegalovirus and herpesvirus research
  • HIV-related health complications and treatments
  • HIV/AIDS Research and Interventions
  • Hepatitis C virus research
  • Liver Disease Diagnosis and Treatment

Van Lunzen has published in several journals and venues, with frequent contributions to:

  • Frontiers in Immunology (4 publications)
  • AIDS (2 publications)
  • Open Forum Infectious Diseases (2 publications)
  • Nature Medicine (1 publication)
  • JCI Insight (1 publication)

Their recent papers include:

  • "Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021" (2021, Nature Medicine)
  • "Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis" (2021, AIDS)
  • "Chronic HIV infection induces transcriptional and functional reprogramming of innate immune cells" (2021, JCI Insight)
  • "Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1" (2020, Science Translational Medicine)
  • "The 2000HIV study: Design, multi-omics methods and participant characteristics" (2022, Frontiers in Immunology)

Frequent co-authors in van Lunzen's research include:

  • Leo A. B. Joosten
  • W Vos
  • Albert L. Groenendijk
  • Marc J. T. Blaauw
  • Louise E. van Eekeren

Best Publications

  • Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

    Alison J. Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

    Bonaventura Clotet;Judith Feinberg;Jan Van Lunzen;Marie Aude Khuong-Josses

  • Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48.

    Roberto Ortiz;Edwin DeJesus;Homayoon Khanlou;Evgeniy Voronin

  • Expansion of HIV-specific T follicular helper cells in chronic HIV infection.

    Madelene Lindqvist;Jan van Lunzen;Damien Z. Soghoian;Bjorn D. Kuhl

  • International AIDS Society global scientific strategy: towards an HIV cure 2016

    Steven G Deeks;Sharon R Lewin;Anna Laura Ross;Jintanat Ananworanich

  • Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy.

    Linqi Zhang;Sharon R. Lewin;Martin Markowitz;Hsi-Hsun Lin

  • Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement

    Christoph Lange;Ibrahim Abubakar;Jan Willem C. Alffenaar;Graham Bothamley

  • Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

    Jan van Lunzen;Franco Maggiolo;José R Arribas;Aza Rakhmanova

  • Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study

    Anthony Mills;Jose R. Arribas;Jaime Andrade-Villanueva;Giovanni DiPerri

  • Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

    Christine Katlama;Steven G Deeks;Brigitte Autran;Javier Martinez-Picado

  • Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.

    Steven G. Deeks;Nancie Archin;Paula Cannon;Simon Collins

  • MyD88-Dependent Immune Activation Mediated by Human Immunodeficiency Virus Type 1-Encoded Toll-Like Receptor Ligands

    Angela Meier;Galit Alter;Nicole Frahm;Harlyn Sidhu

  • The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy.

    Klara Tenner-Racz;Hans-Jürgen Stellbrink;Jan van Lunzen;Claus Schneider

  • Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study

    Jean Michel Molina;Bonaventura Clotet;Jan van Lunzen;Adriano Lazzarin

  • Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study.

    V Miller;A Mocroft;P Reiss;C Katlama

  • Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients

    Christoph Wyen;Heidy Hendra;Martin Vogel;Christian Hoffmann

  • Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.

    Julian Schulze zur Wiesch;Julian Schulze zur Wiesch;Adriana Thomssen;Adriana Thomssen;Philip Hartjen;Philip Hartjen;Ilona Tóth;Ilona Tóth

  • Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus.

    Jan van Lunzen;Tobias Glaunsinger;Ingrid Stahmer;Volker von Baehr

  • Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection.

    Norma Jung;Clara Lehmann;Andrea Rubbert;Meike Knispel

  • Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe

    Roger Paredes;Amanda Mocroft;Ole Kirk;Adriano Lazzarin

Frequent Co-Authors

Gerd Fätkenheuer
Gerd Fätkenheuer University of Cologne
Marcus Altfeld
Marcus Altfeld University Medical Center Hamburg-Eppendorf
Jürgen K. Rockstroh
Jürgen K. Rockstroh University Hospital Bonn
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Joachim Hauber
Joachim Hauber Heinrich-Pette-Institute
Bruce D. Walker
Bruce D. Walker Harvard University
Amanda Mocroft
Amanda Mocroft University College London
Ansgar W. Lohse
Ansgar W. Lohse Universität Hamburg
Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry can open doors to diverse, rewarding careers in healthcare and life sciences. If you’re seeking flexible learning options or wish to complement your primary studies, numerous affordable online programs can help you gain specialized knowledge and skills.

For those interested in data management within healthcare settings, a bachelor's degree health information management provides a strong foundation in organizing, handling, and protecting patient health data. This path blends healthcare knowledge with information technology, meeting a critical demand in today’s medical industry.

If nutrition and wellness inspire you, an online master's degree in nutrition can enhance your scientific understanding and lead to careers as a nutritionist, educator, or consultant. For those interested in diagnostic imaging, online sonography certificate programs and online radiology tech programs offer direct pathways into rapidly growing health tech fields.

These online degrees offer flexible options to expand your career prospects, deepen your expertise, or transition into new roles related to Biology and Biochemistry.

Best Scientists Citing Jan van Lunzen

Trending Scientists

Recently Published Articles